Delaware Street Drug Report
July 2026 | Report #2026-13
Approved: July 23, 2026
Contact: ORC@delaware.gov
Disclaimer
This report is for risk mitigation and educational purposes only and should not be used for professional or publication use. The data included is from sporadic drug residue testing across various locations in Delaware and should not be over generalized. Stamp names are not universal or consistent in the street supply and are provided here for reference only.
The selected stamps below are from samples collected during June 2026.
Select Stamps and Compounds Detected
AK-47
4-ANPP, Cocaine, Fentanyl, Medetomidine, Phenacetin, Procaine, Tetracaine
Blood Party
Cocaine, Medetomidine
Blood Party
4-ANPP, Cocaine, Fentanyl, Medetomidine, Quinine, Tetracaine
Demon
Fentanyl, Medetomidine, Tetracaine
Grilled Cheese
Fentanyl, Lidocaine, Medetomidine, Tetracaine
Honda
Fentanyl, Medetomidine, Tetracaine
Honey
4-ANPP, Cocaine, Fentanyl, Lidocaine, Phenacetin, Procaine, +2 others
Maria
4-ANPP, Fentanyl, Medetomidine, Procaine, Tetracaine
Nike
Fentanyl, Heroin, Lidocaine, Medetomidine, Procaine, Tetracaine, +3 others
Pepsi
Fentanyl, Medetomidine, Tetracaine
Toyota
Fentanyl, Medetomidine, Procaine, Tetracaine
U-Haul
Caffeine, Fentanyl, Medetomidine
Used Device
Cocaine, Phenacetin
Used Device
Cocaine, Methamphetamine
Substance Highlights
Phenacetin
Phenacetin is commonly used as an adulterant in cocaine and more recently opioid supplies. It is a known carcinogen (proven cause of cancer), is toxic to the kidneys, and can damage the heart, blood, and urinary system.
Medetomidine
Like xylazine, medetomidine is a veterinary tranquilizer not approved for human use, but it is considered to be more potent. Common adverse side effects are sedation, bradycardia, and severe withdrawal symptoms.
Cocaine
An intense, DEA Schedule II stimulant with strong addictive potential that causes restlessness, paranoia, insomnia, loss of appetite, irregular heartbeat, and seizures.
Trending Substances
| Compound Detected | Jan. 2026 | Feb. 2026 | Mar. 2026 | Apr. 2026 | May 2026 | Jun. 2026 |
|---|---|---|---|---|---|---|
| Samples Tested | 47 | 25 | 17 | 42 | 64 | 137 |
| Xylazine | 13% | 8% | 35% | 2% | 5% | 1% |
| Medetomidine | 66% | 88% | 65% | 21% | 36% | 24% |
| Fentanyl | 98% | 96% | 77% | 71% | 42% | 23% |
| Tetracaine | 45% | 84% | 24% | 43% | 27% | 20% |
| Procaine | 49% | 84% | 24% | 45% | 11% | 7% |
| Lidocaine | 19% | 20% | 6% | 2% | 9% | 4% |
| 4-ANPP | 79% | 52% | 41% | 29% | 11% | 8% |
| BTMPS | 26% | 4% | 0% | 0% | 0% | 0% |
| Fluorofentanyl | 0% | 0% | 0% | 0% | 0% | 0% |
| Cocaine | 28% | 8% | 29% | 37% | 56% | 70% |
| Methamphetamine | 0% | 8% | 18% | 7% | 6% | 3% |
| Pregabalin | 0% | 0% | 0% | 0% | 0% | 0% |
| Heroin | 36% | 4% | 0% | 2% | 0% | 1% |
| Carfentanil | 0% | 0% | 0% | 0% | 0% | 0% |
| Quinine | 26% | 4% | 0% | 2% | 0% | 1% |
| Levamisole | 0% | 0% | 6% | 2% | 2% | 0% |
June 2026 Trends
Continuing the trend from previous months, the prevalence of cocaine reached 70% of samples tested, the highest prevalence rate so far. Approximately 16% of samples containing cocaine this month also contained phenacetin.
It is important to remember that this testing is a convenience sample, meaning the vast majority of samples are volunteered by individuals to be tested and is not a random or even sampling of the general Delaware drug supply.
It continues to be very unlikely that the drop in fentanyl/medetomidine detection and the increase in cocaine detection levels is a shift in the general drug supply. Instead, this change in prevalence is mostly driven from users of stimulants increasingly submitting samples for testing.